TCL Archive DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says May 31, 1991
TCL Archive VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds July 25, 2008
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014